Infection

, Volume 37, Issue 2, pp 96–102 | Cite as

High Prevalence of Latent Tuberculosis Infection in Patients in End-Stage Renal Disease on Hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and Tuberculin Skin Test

  • S. S. J. Lee
  • K. J. Chou
  • I.J. Su
  • Y. S. Chen
  • H. C. Fang
  • T. S. Huang
  • H. C. Tsai
  • S. R. Wann
  • H. H. Lin
  • Y. C. Liu
Clinical and Epidemiological Study

Abstract

Background:

Individuals with end-stage renal disease (ESRD) are 10- to 25-fold more likely than immunocompetent people to develop active tuberculosis (TB) and are candidates for being treated for latent TB infection (LTBI). However, diagnosis using the tuberculin skin test (TST) is doubly difficult due to cutaneous anergy and cross-reactions with Bacille–Calmette–Guérin (BCG) vaccination.

Materials and Methods:

This was a prospective, doublematched, cohort study in which 32 ESRD patients and 32 age-matched, healthy controls were enrolled. The TST and two new interferon-γ blood tests, QuantiFERON-TB Gold (QFT-G) and T-SPOT.TB (ELISPOT), were performed. The subjects were followed up 2 years for active TB disease. ELISPOT was done in ESRD patients only.

Results:

Compared to the healthy controls, a high prevalence of LTBI was found in the ESRD patients by TST (62.5%, 95% confidence interval [CI] 43.7–78.9), QFT-G (40.0%, 95% CI 22.7–59.4), and ELISPOT (46.9%, 95% CI 29.1–65.3). Agreement was moderate (kappa [κ] = 0.53) for QFT-G and ELISPOT but only slight between TST and QFT-G (κ = 0.25) and fair between TST and ELISPOT (κ = 0.32). ESRD (p = 0.03) and diabetes mellitus (p = 0.04) were significant risk factors for QFT-G positivity on the multivariable analysis. The overall rate of active TB was 1.66 cases per 100 person-years (pys), with the rate higher in patients with ESRD (3.53 per 100 pys) and those with positive (3.40 per 100 pys) and indeterminate QFT results (30.16 per 100 pys), although the difference was not statistically significant. Sensitivity, specificity, and positive and negative predictive values of QFT-G for active TB was 100%, 62.1%, 8.3% and 100%.

Conclusion:

This pilot study is the first to compare QFT-G, ELISPOT, and TST in ESRD patients on hemodialysis and demonstrates a high prevalence of LTBI in this population. In our study, the QFT-G was the more accurate method for identifying those truly infected with Mycobacterium tuberculosis, even in BCG-vaccinated individuals.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    WHO. 2007 WHO Fact Sheet. Available at: http://www.who.int/tb/publications/2007/factsheet_2007.pdf. Accessed 15 July 2007.
  2. 2.
    CDC Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221–S247.Google Scholar
  3. 3.
    Smirnoff M, Patt C, Seckler B, Adler JJ: Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998; 113: 25–27.PubMedCrossRefGoogle Scholar
  4. 4.
    Lundin AP, Adler AJ, Berlyne GM, Friedman EA: Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979; 67: 597–602.PubMedCrossRefGoogle Scholar
  5. 5.
    Chia S, Karim M, Elwood RK, FitzGerald JM: Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis 1998; 2: 989–991.PubMedGoogle Scholar
  6. 6.
    Sester U, Junker H, Hodapp T, Schutz A, Thiele B, Meyerhans A, Kohler H, Sester M: Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transplant 2006; 21: 3258–3268.PubMedCrossRefGoogle Scholar
  7. 7.
    Fang HC, Lee PT, Chen CL, Wu MJ, Chou KJ, Chung HM: Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis 2004; 8: 92–97.PubMedGoogle Scholar
  8. 8.
    Yanai M, Uehara Y, Takeuchi M, Nagura Y, Hoshino T, Hayashi K, Kumasaka K: Evaluation of serological diagnosis tests for tuberculosis in hemodialysis patients. Ther Apher Dial 2006; 10: 278–281.PubMedCrossRefGoogle Scholar
  9. 9.
    Venkata RK, Kumar S, Krishna RP, Kumar SB, Padmanabhan S, Kumar S: Tuberculosis in chronic kidney disease. Clin Nephrol 2007; 67: 217–220.PubMedGoogle Scholar
  10. 10.
    Dervisoglu E, Yilmaz A, Sengul E: The spectrum of tuberculosis in dialysis patients. Scand J Infect Dis 2006; 38: 1040–1044.PubMedCrossRefGoogle Scholar
  11. 11.
    Chou KJ, Fang HC, Bai KJ, Hwang SJ, Yang WC, Chung HM: Tuberculosis in maintenance dialysis patients. Nephron 2001; 88: 138–143.PubMedCrossRefGoogle Scholar
  12. 12.
    Klote MM, Agodoa LY, Abbott KC: Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients. Nephrol Dial Transplant 2006; 21: 3287–3292.PubMedCrossRefGoogle Scholar
  13. 13.
    Centers for Disease Control and Prevention (CDC): Tuberculosis transmission in a renal dialysis center — Nevada, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 873–875.Google Scholar
  14. 14.
    Lee E, Holzman RS: Evolution and current use of the tuberculin test. Clin Infect Dis 2002; 34: 365–370.PubMedCrossRefGoogle Scholar
  15. 15.
    Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V: The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005; 20: 2720–2724.PubMedCrossRefGoogle Scholar
  16. 16.
    Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM: A meta-analysis of the effect of Bacille-Calmette-Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804–809.PubMedCrossRefGoogle Scholar
  17. 17.
    Pai M, Riley LW, Colford JMJr: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761–776.PubMedCrossRefGoogle Scholar
  18. 18.
    Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340–354.PubMedGoogle Scholar
  19. 19.
    Mazurek GH, Villarino ME: Guidelines for using the Quanti-FERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 15–18.PubMedGoogle Scholar
  20. 20.
    Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV: Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007; 175: 737–742.PubMedCrossRefGoogle Scholar
  21. 21.
    Kunimoto D, Birse T, Lindemulder A, Manning T, Miedzinski L, Saxinger L, Shafran S, Taylor G, Houston S. QuantiFERON-TB Gold testing of HIV patients for latent TB infection. Can J infect Dis Med Microbiol 2006; 17.Google Scholar
  22. 22.
    Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, Wilkinson RJ: Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175: 514–520.PubMedCrossRefGoogle Scholar
  23. 23.
    Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P: Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006; 7: 56.PubMedCrossRefGoogle Scholar
  24. 24.
    Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M: Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007; 2: 68–73.PubMedCrossRefGoogle Scholar
  25. 25.
    Cellestis Ltd.: QuantiFERON®-TB Gold Analysis Software. Available at: http://www.cellestis.com/IRM/content/aust/SoftwareDownloadAU.aspx. Accessed 24 July 2007.
  26. 26.
    CDC-Taiwan: Taiwan guideline on TB diagnosis and treatment. In: CDC-Taiwan (eds): 2nd edn. Taiwan Centers for Disease Control, Taipei 2006.Google Scholar
  27. 27.
    Landis JR, Koch GG: An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363–374.PubMedCrossRefGoogle Scholar
  28. 28.
    Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH: Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59–65.PubMedCrossRefGoogle Scholar
  29. 29.
    Korzets A, Gafter U: Tuberculosis prophylaxis for the chronically dialysed patient-yes or no? Nephrol Dial Transplant 1999; 14: 2857–2859.PubMedCrossRefGoogle Scholar
  30. 30.
    Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A: Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 1164–1170.PubMedCrossRefGoogle Scholar
  31. 31.
    Sester M, Sester U, Clauer P, Heine G, Mack U, Moll T, Sybrecht GW, Lalvani A, Kohler H: Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65: 1826–1834.PubMedCrossRefGoogle Scholar
  32. 32.
    Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W: Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 2006; 44: 2844–2850.PubMedCrossRefGoogle Scholar
  33. 33.
    Ferrara G, Losi M, D’Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328–1334.PubMedCrossRefGoogle Scholar
  34. 34.
    Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D’Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L: Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631–635.PubMedCrossRefGoogle Scholar
  35. 35.
    Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T: Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7: 77.PubMedCrossRefGoogle Scholar
  36. 36.
    Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756–2761.PubMedCrossRefGoogle Scholar
  37. 37.
    Mahomed H, Hughes EJ, Hawkridge T, Minnies D, Simon E, Little F, Hanekom WA, Geiter L, Hussey GD: Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10: 310–316.PubMedGoogle Scholar
  38. 38.
    Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27: 442–448.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • S. S. J. Lee
    • 1
    • 2
  • K. J. Chou
    • 2
    • 3
  • I.J. Su
    • 4
  • Y. S. Chen
    • 1
    • 2
    • 5
  • H. C. Fang
    • 2
    • 3
  • T. S. Huang
    • 2
    • 6
    • 7
  • H. C. Tsai
    • 1
    • 2
  • S. R. Wann
    • 1
    • 2
  • H. H. Lin
    • 8
  • Y. C. Liu
    • 1
    • 2
    • 7
  1. 1.Section of Infectious Diseases, Dept. of MedicineKaohsiung Veterans General HospitalKaohsiungTaiwan
  2. 2.National Yang-Ming UniversityTaipeiTaiwan
  3. 3.Section of Nephrology, Dept. of MedicineKaohsiung Veterans General HospitalKaohsiungTaiwan
  4. 4.Division of Clinical ResearchNational Health Research InstitutesMiaoliTaiwan
  5. 5.Graduate Institute of Environmental EducationNational Kaohsiung Normal UniversityKaohsiungTaiwan
  6. 6.Dept. of Medical TechnologyFoo-Yin Institute of TechnologyKaohsiungTaiwan
  7. 7.Section of Microbiology and Infectious DiseasesKaohsiung Veterans General HospitalKaohsiungTaiwan
  8. 8.Section of Infectious DiseasesE-Da Hospital/I-Shou UniversityKaohsiungTaiwan

Personalised recommendations